|
100
|
249
|
5t8eA |
Synthesis and biological evaluation of novel selective androgen receptor modulators (sarms). part ii: optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives |
|
63
|
216
|
5t97A |
Estrogen receptor alpha ligand binding domain in complex with (2e)-3-(4-{(1r)-6-hydroxy-1-methyl-2-[4-(propan-2 -yl)phenyl]-1,2,3,4- tetrahydroisoquinolin-1-yl}phenyl)prop-2-enoic acid |
|
96
|
249
|
5t8jA |
Synthesis and biological evaluation of novel selective androgen receptor modulators (sarms). part ii: optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives |
|
67
|
216
|
5t92A |
Estrogen receptor alpha ligand binding domain in complex with (2e)-3-{4-[(1r)-2-(4-fluorophenyl)-6-hydroxy-1-methy l-1,2,3,4- tetrahydroisoquinolin-1-yl]phenyl}prop-2-enoic acid |
|
96
|
239
|
5syzA |
Human liver receptor homologue-1 (lrh-1) bound to a rjw100 stereoisomer and a fragment of tif-2 |
|
95
|
245
|
5t1zA |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with ethoxytriphenylethylene and grip peptide |
|
93
|
229
|
5q0xA |
Ligand binding to farnesoid-x-receptor |
|
90
|
230
|
5q0uA |
Ligand binding to farnesoid-x-receptor |
|
93
|
230
|
5q1dA |
Ligand binding to farnesoid-x-receptor |
|
95
|
232
|
5q13A |
Ligand binding to farnesoid-x-receptor |
|
90
|
227
|
5q10A |
Ligand binding to farnesoid-x-receptor |
|
93
|
229
|
5q0iA |
Ligand binding to farnesoid-x-receptor |
|
84
|
228
|
5q0qA |
Ligand binding to farnesoid-x-receptor |
|
84
|
229
|
5q1fA |
Ligand binding to farnesoid-x-receptor |
|
85
|
227
|
5q11A |
Ligand binding to farnesoid-x-receptor |
|
92
|
230
|
5q0pA |
Ligand binding to farnesoid-x-receptor |
|
89
|
228
|
5q0kA |
Ligand binding to farnesoid-x-receptor |
|
90
|
230
|
5q15A |
Ligand binding to farnesoid-x-receptor |
|
92
|
230
|
5q0vA |
Ligand binding to farnesoid-x-receptor |
|
93
|
230
|
5q19A |
Ligand binding to farnesoid-x-receptor |
|
75
|
230
|
5q0lA |
Ligand binding to farnesoid-x-receptor |
|
91
|
230
|
5q18A |
Ligand binding to farnesoid-x-receptor |
|
90
|
228
|
5q1iA |
Ligand binding to farnesoid-x-receptor |
|
90
|
230
|
5q0jA |
Ligand binding to farnesoid-x-receptor |
|
90
|
228
|
5q1eA |
Ligand binding to farnesoid-x-receptor |
|
90
|
230
|
5q1bA |
Ligand binding to farnesoid-x-receptor |
|
94
|
230
|
5q1aA |
Ligand binding to farnesoid-x-receptor |
|
91
|
228
|
5q12A |
Ligand binding to farnesoid-x-receptor |
|
91
|
228
|
5q0mA |
Ligand binding to farnesoid-x-receptor |
|
85
|
229
|
5q1gA |
Ligand binding to farnesoid-x-receptor |
|
91
|
229
|
5q1cA |
Ligand binding to farnesoid-x-receptor |
|
89
|
230
|
5q14A |
Ligand binding to farnesoid-x-receptor |
|
89
|
230
|
5q0sA |
Ligand binding to farnesoid-x-receptor |
|
81
|
230
|
5q0zA |
Ligand binding to farnesoid-x-receptor |
|
100
|
299
|
5ow9A |
Vitamin d receptor complex |
|
103
|
300
|
5ow7A |
Vdr complex |
|
97
|
299
|
5owdA |
Vitamin d receptor complex |
|
89
|
234
|
5ntqA |
Structural states of rorgt: x-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds |
|
99
|
245
|
5ntnA |
Structural states of rorgt: x-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds |
|
99
|
245
|
5ntwA |
Structural states of rorgt: x-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds |
|
96
|
245
|
5nu1A |
Structural states of rorgt: x-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds |
|
84
|
225
|
5ntkA |
Structural states of rorgt: x-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds |
|
94
|
298
|
5nkyA |
Structure-activity relationship study of vitamin d analogs with oxolane group in their side chain |
|
97
|
245
|
5ntiA |
Structural states of rorgt: x-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds |
|
96
|
252
|
5ni7A |
Ligand complex of rorg lbd |
|
90
|
299
|
5nmaA |
Structure-activity relationship study of vitamin d analogs with oxolane group in their side chain |
|
91
|
230
|
5ntpA |
Structural states of rorgt: x-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds |
|
99
|
252
|
5nibA |
Ligand complex of rorg lbd |
|
85
|
229
|
5mk4A |
Crystal structure of the retinoid x receptor alpha in complex with synthetic honokiol derivative 7 and a fragment of the tif2 co-activator. |
|
90
|
241
|
5c4uA |
Identification of a novel allosteric binding site for rorgt inhibitors |
